Acute Myopericarditis Post-Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Differs From Viral Myocarditis

Clin Infect Dis. 2022 Aug 24;75(1):e926. doi: 10.1093/cid/ciab980.
No abstract available

Publication types

  • Editorial

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Injections, Intravenous
  • Myocarditis* / drug therapy
  • Myocarditis* / virology
  • Pericarditis* / drug therapy
  • Pericarditis* / virology
  • RNA, Messenger / therapeutic use
  • Vaccines, Synthetic
  • Virus Diseases*
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • Vaccines, Synthetic
  • mRNA Vaccines